LENZ – lenz therapeutics, inc. (US:NASDAQ)

News

LENZ Therapeutics: Speculative But Strong Buy [Seeking Alpha]
The Consensus EPS Estimates For LENZ Therapeutics, Inc. (NASDAQ:LENZ) Just Fell Dramatically [Yahoo! Finance]
Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week [Yahoo! Finance]
LENZ Therapeutics: Q4 Results Highlight A Worrying Lack Of Market Demand (Rating Downgrade) [Seeking Alpha]
LENZ Therapeutics (LENZ) had its price target lowered by Citigroup Inc. from $52.00 to $26.00. They now have a "buy" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com